Showing results (191-200 of 239) with videos related to

Sort By:
Pageof 24
The Lancet. Oncology|September 16, 2011
HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient dataAngelo Di Leo, Christine Desmedt, John M S Bartlett, et al.
Breast (Edinburgh, Scotland)|May 7, 2025
Physicians' knowledge, practice, and attitudes on fertility and pregnancy-related issues in young women with advanced breast cancer: results of the ABC6 and ABC7 surveySimone Nardin, Luca Arecco, Virginia Delucchi, et al.
The New England Journal of Medicine|September 16, 2024
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Rebecca Dent, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2007
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)Rosa Giuliani, Virginie Durbecq, Angelo Di Leo, et al.
Breast (Edinburgh, Scotland)|February 10, 2015
Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?Olivia Pagani, Monica Ruggeri, Silvia Manunta, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation studyAbigirl Machingura, Mekdes Taye, Jammbe Musoro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smallerAna M Gonzalez-Angulo, Jennifer K Litton, Kristine R Broglio, et al.
Psycho-Oncology|October 13, 2023
Well-being trajectories in breast cancer and their predictors: A machine-learning approachEvangelos C Karademas, Eugenia Mylona, Ketti Mazzocco, et al.
NPJ Breast Cancer|December 20, 2025
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastasesKatarzyna J Jerzak, Evangelia D Razis, Elisa Agostinetto, et al.
Breast (Edinburgh, Scotland)|March 11, 2011
Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global InitiativeCheng-Har Yip, Eduardo Cazap, Benjamin O Anderson, et al.
Pageof 24